TrialTrials2017

A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.

Katrin Lorenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.